We are hiring a Clinical Study Manager

We are hiring a Clinical Study Manager!   The Clinical Study Manager (CSM) is responsible for the overall management of allocated clinical trials in the CRO department, in accordance with International Conference on Harmonization Good Clinical Practices (ICH-GCP), applicable regulations, SOPs and Wis. Essential Duties and Responsibilities include, but are not limited to, the following: […]

VectorB2B will be at “BioSpain”

Vector B2B will be participating at the BIOSPAIN: Trade Show and Partnering taking place on 27th October 2021 in Pamplona-Iruña, Spain. BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+773).  Virtual […]

VectorB2B will be at “Skin Microbiome & Cosmeceuticals Congress: Europe”

Vector B2B will be participating at the Skin Microbiome & Cosmeceuticals Congress: Europe taking place on 26th-27th October 2021 in Rotterdam, The Netherlands. Dedicated to exploring the burgeoning field of skin microbiome research, the 3rd edition of the Skin Microbiome & Cosmeceuticals Congress: Europe brings together KOLs to present case studies focusing on topics such as […]

VectorB2B will be at the “Swiss Biotech Day”

Vector B2B will be present at the Swiss Biotech Day taking place on 7th September 2021 at the Congress Center Basel, Switzerland. The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe. This year’s event gathers exhibitions throughout the day, delegations from various countries, thematically focused panel discussions, pre-scheduled one-to-one partnering meetings and a […]

VectorB2B organiza Mesa Redonda: “Experimentar o Futuro – As novas tecnologias e os desafios na inovação em neurociências”

A VectorB2B – Drug Development organiza a Mesa Redonda: “Experimentar o Futuro: As novas tecnologias e os desafios de inovação em Neurociências”, no âmbito das comemorações do Dia Mundial do Cérebro. Este evento pretende facilitar sinergias, promovendo a ligação estratégica entre sectores inovadores e transversais no âmbito da investigação em Neurociências. Fazem parte do painel […]

VectorB2B will be at “Bio-Europe Spring 2021”

Vector B2B will be participating in the Bio-Europe Spring 2021 between March 22-25. Bio-Europe Spring is the European largest springtime digital partnering event with the aim of connecting the right partners in Life Sciences. It features workshops and company presentations with the main focus of providing the right environment for interaction and partnering opportunities. Participating companies will […]

Leading partner in TechnoPhage Clinical Trial

Vector B2B – Drug Development has been elected as the lead partner to manage the TechnoPhage clinical trial on Diabetic Foot Ulcers. TechnoPhage trusted Vector B2B – Drug Development to conduct the TP-102_101/REVERSE study, a Phase I/IIa Double-Blind Randomized Clinical Trial to determine the safety and tolerability of the bacteriophage cocktail TP-102 in subjects with […]

VectorB2B will be at “Phage Futures Congress 2021”

We are very pleased to announce that our Head of CMC, Teresa Duarte, will be a special guest of Cellexus joining the Phage Futures Congress. Teresa will be participating in the panel session at Phage Futures, hosted by Adam Ostrowski, Technical Application Specialist at Cellexus. Other participants include Jonathan Kotula, Head of Science at Felix Biotechnology, Rodrigo […]

VectorB2B will be at “Infectious Diseases Virtual Partnering”

We are very pleased to be attending the Infectious Diseases Virtual Partnering from 2-4 December, 2020. If you have any questions, please contact our specialist. Vector B2B – Drug Development will present our new services available to all pharmaceutical & biotechnology companies developing new treatments for many infectious diseases for which there are not satisfactory preventive tools […]